TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88232299

Filing Date: 12/17/2018

To the Commissioner for Trademarks:

MARK: SIMPLICIT90Y (stylized and/or with design, see mark)

The literal element of the mark consists of SIMPLICIT90Y.
The applicant is not claiming color as a feature of the mark. The mark consists of the letters " SIMPLICIT " with the number "90" as a superscript followed by the letter "Y".
The applicant, Biocompatibles UK Limited, a limited company (ltd.) legally organized under the laws of United Kingdom, having an address of
      Chapman House
      Farnham Business Park, Weydon Lane
      Farnham, Surrey GU98QL
      United Kingdom

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 009:  Computer software; computer software for dosimetry; computer software for dosimetry purposes in the field of radiotherapy; computer software for use in accelerating dosimetry planning; computer software for use in creating reports; computer software for use in facilitating personalised treatment plans for patients with liver cancer; computer software for use In reviewing and reporting on medical images; computer software for use in data display, quality control, image manipulation and quantification analysis; computer software for use in post treatment validation; computer software for creating patient profiles and providing patient reports; computer software for recording, analysing, reporting and managing patient medical information; computer software used as medical patient monitoring equipment, for receiving, processing, transmitting and displaying data

In International Class 009, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 09/07/2016, and first used in commerce at least as early as 09/22/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Specimen 1: screenshot showing the mark while the computer software is running (please see upper left corner of the screenshot) Specimen 2: PDF copy of an instruction manual showing the mark in connection with the goods pursuant to Section 904.03(j) of the TMEP.
JPG file(s):
Specimen File1
Original PDF file:
SPE0-17322719112-20181217165851170881_._Specimen_2_-_RJENK67.046TUS.pdf
Converted PDF file(s) (18 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Specimen File7
Specimen File8
Specimen File9
Specimen File10
Specimen File11
Specimen File12
Specimen File13
Specimen File14
Specimen File15
Specimen File16
Specimen File17
Specimen File18

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Great Britain application number 3355614, filed 11/22/2018.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The applicant's current Attorney Information:
      Jonathan A. Hyman and John B. Sganga, Jr., Edward A. Schlatter, Gerard von Hoffmann, Joseph R. Re, Catherine J. Holland, John M. Carson, Karen Vogel Weil, Jeffrey L. Van Hoosear, Daniel E. Altman, Lynda J. Zadra-Symes, William H. Shreve, Stephen C. Jensen, Steven J. Nataupsky, Paul A. Stewart, Joseph F. Jennings, Craig S. Summers, Diane M. Reed, Ronald J. Schoenbaum, John R. King, Adeel S. Akhtar, David N. Weiss, Douglas G. Muehlhauser, Lori Lee Yamato, Michael K. Friedland, Stacey R. Halpern, Mark M. Abumeri, Jon W. Gurka, John W. Holcomb, Joseph M. Reisman, Michael L. Fuller, Mark R. Benedict, Paul N. Conover, Robert J. Roby, Sabing H. Lee, Karoline A. Delaney, Joseph S. Cianfrani, William R. Zimmerman, Paul C. Steinhardt, Eric S. Furman, Susan M. Natland, Rose M. Thiessen, Michael A. Guiliana, Rabinder N. Narula, Bruce S. Itchkawitz, John M. Grover, Irfan A. Lateef, Amy Christensen Chun, Mark J. Gallagher, David G. Jankowski, Brian C. Horne, Payson LeMeilleur, Sheila N. Swaroop, Benjamin A. Katzenellenbogen, Andrew N. Merickel, Thomas P. Krzeminski, Linda H. Liu, James F. Herkenhoff, Andrew M. Douglas, Salima A. Merani, Jonathan A. Hyman, Curtiss C. Dosier, Joseph J. Mallon, Sean M. Murray, Christy G. Lea, Perry D. Oldham, Russell M. Jeide, Zi Y. Wong, Matthew S. Bellinger, Mincheol Kim, Gregory A. Hermanson, Lauren Keller Katzenellenbogen, Ted M. Cannon, Carol Pitzel Cruz, Josué A. Villalta, Andrew I. Kimmel, Brenden Gingrich, Maria Culic Anderson, Melanie J. Seelig, Mauricio A. Uribe, Curtis R. Huffmire, Christopher L. Ross, Eli A. Loots, Ryan E. Melnick, Yanna S. Bouris, Philip M. Nelson, Marko R. Zoretic, Kerry S. Taylor, Derek C. Dailey, Jarom D. Kesler, Steven P. Ruden, Colin B. Heideman, Theodore G. Papagiannis, Nicholas M. Zovko, Adam J. Gilbert, Kimberly J. Miller, Bryan W. Wahl, Thomas Y. Yee, Michelle E. Armond, Agnes Juang, Jason J. Jardine, Jared C. Bunker, Lance D. Smemoe, Joshua J. Stowell, Jonathan E. Bachand, Ali S. Razai, Terry K. Tullis, Derek R. Bayles, Cheryl T. Burgess, Gregory B. Phillips, Brian C. Claassen, Mark Lezama, Sean Ambrosius, Stephen W. Larson, John L. Paik, Bridget O'L. Smith, Michael R. Christensen, Benjamin J. Everton, Jason A. Gersting, Baraa Kahf, Alan G. Laquer, Jing Liu, Vlad Teplitskiy, Jeffery L. Hallstrom, Maria V. Stout, William O. Adams, Ian W. Gillies, Andrew W. Lloyd, Mark D. Kachner, Lincoln S. Essig, David R. Trossen, Aaron M. Davis, Jason R. Swartz, Benjamin B. Anger, Jason A. Champion, Daniel V. Gibson, Jeremy J. Carney, Karen M. Cassidy, Adam B. Powell, Christopher M. DiLeo, Karen J. Lenker, Bryan G. McWhorter, Nathanael R. Luman, Andrea L. Cheek, Deborah S. Shepherd, Alejandro D. Muñoz, Mark D. Marsden, Joan Y. Chan, Allyson G. Brown, Damien J. Howard, Jane Q. Dai, Shannon Lam, Peter Law, Mark Metzke, Scott G. Siera, Vikas Bhargava, Daniel J. Fischer, Jacob Peterson, Christie R.W. Matthaei, Vladimir S. Lozan, Paul S. Stellman, Jeremy A. Anapol, Heungsoo Choi, Scott A. Cromar, Kendall M. Loebbaka, David R. Schmidt, Harnik Shukla, Charlene A. Azema, Morgan R. Coates, Loni L. Morrow, Kyu S. Min, Jane Xia, Chang Sik Lim, Jessica L. Achtsam, Thomas S.H. Cowan, Nicole Rossi Townes, Devanie A. DuFour, Alexander J. Martinez, Hans L. Mayer, Jessica C. Sganga, Nicholas A. Belair, Ryan S. Furtado, Jonathan A. Menkes, Angela K. Dremann, Justin J. Gillett, M. Scott Forbes, Brian M. Graham, Brian J. Flynn, Mitchell B. Hadley, Qi Peter Tong, Elenore Niu, Michael P. Burns, Paul Chang, David M. Cohen, Mark E. Davis, Jordan Gottdank, Kim A. Kennedy, Daniel C. Kiang, Keith M. Lim, Ashley C. Morales, Nathan D. Reeves, Scott R. Seeley, Brandon G. Smith, Diana E. Wade, Xiaoyan Sabrina Wang, April K. White, Zach Jun Hyuk Hong, Jordan M. Cox, Albert J. Sueiras, Mark Rubinshtein, David J. Grant, Clayton R. Henson, Daniel A. Kamkar, Lesley Y. Kim, Nathan J. Lee, Josepher Li, Vicki Y. Nee, Jacob R. Rosenbaum, James F. Smith, Douglas B. Wentzel, Thomas E. Woodland, Derek M. Abeyta, Aryeh N. Feinstein, Noorean I. Gill, Shuchen Gong, Peter A. Hecker, Aaron S. Johnson, Bryan J. Johnson, David C. Kellogg, Chanell Khosrowabadi, Lindsay A. Laddaran, Forrest M. McClellen, Janet M. Olsen, Alexander Zeng, Drew S. Hamilton, Andrew H. Simpson, Jeremiah S. Helm, Rosaleen H. Chou, Hironori Kubota, Andrew D. Lee, Yusuke Hirai, Sean S. Kim, Benjamin Ho, Bita Kianian, Serah R. Friedman, Eric R. Malmgren, Brian M.Z. Reece, and Derk A. Westermeyer of Knobbe Martens Olson and Bear, LLP      2040 Main St., 14th Floor
      Irvine, California 92614
      United States
      310-551-3450(phone)
      949-760-9502(fax)
      efiling@knobbe.com (authorized)
The attorney docket/reference number is RJENK67.046T.

The applicant's current Correspondence Information:

Jonathan A. Hyman

Knobbe Martens Olson and Bear, LLP

2040 Main St., 14th Floor

Irvine, California 92614

310-551-3450(phone)

949-760-9502(fax)

efiling@knobbe.com;jonathan.hyman@knobbe.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Payment Sale Number: 88232299
Payment Accounting Date: 12/18/2018

Serial Number: 88232299
Internet Transmission Date: Mon Dec 17 17:39:14 EST 2018
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.XXX-201812171739142
03316-88232299-620ceb6d4d540e5984806c601
0f54dc470261dd14eb23b915ada654bab21fc2d-
CC-5254-20181217173059481085